All our news.

Countries.
Years.
France
2026
April 17, 2026

Communiqué de presse. Opella célèbre 60 ans d’histoire à Compiègne.

Read more.
Global
2026
April 13, 2026

Press Release. Contaminated, mislabelled, interchangeable: experts sound the alarm on probiotic quality in children's care.

Read more.
Global
2026
March 31, 2026

Press Release. Opella appoints Gonzalo Balcazar as President of Europe and Latin America.

Read more.
Australia​
2026
March 20, 2026

Press Release. Opella Healthcare launches breakthrough electrification project with the backing of $1.94M in Australian federal funds.

Read more.
Japan
2026
March 13, 2026

Press Release. SSP Co., Ltd. announces appointment of new President and General Manager.

Read more.
Global
2026
March 12, 2026

Press Release. Opella and Verb Biotics Join Forces for Gut Health.

Read more.
Brazil
2026
March 5, 2026

Press Release. Patricia Castro é a nova Diretora da fábrica de Opella em Suzano.

Read more.
Global
2026
March 5, 2026

Press Release. Opella and FIP launch 5-year strategic partnership to advance global self-care.

Read more.
Colombia
2026
February 11, 2026

Comunicado de prensa. Opella fortalece su liderazgo en el autocuidado con la llegada de Melanie Cooper como nueva General Manager para SOCOPAC.

Read more.
Mexico
2026
February 10, 2026

Comunicado de prensa. Opella nombra a Luis Soares como Director General en México y refuerza su estrategia de crecimiento en el país.

Read more.
Czech Republic
2026
February 4, 2026

Tisková zpráva. Václav Tetour jmenován ředitelem pro Česko a Slovensko ve společnosti Opella.

Read more.
Slovakia
2026
February 4, 2026

Tlačová správa. Václav Tetour sa stal riaditeľom pre Česko a Slovensko v spoločnosti Opella.

Read more.
France
2025
17 Novembre 2025

Communiqué de presse. Opella investit 40 millions d’euros dans son appareil industriel à l’occasion de Choose France.

Read more.
Global
2025
November 4, 2025

Press Release. Opella’s net-zero target validated by SBTi.

Read more.
France
2025
October 9, 2025

Communiqué de Presse. 75% des femmes voient leur sommeil se dégrader à la ménopause.

Read more.
Brazil
2025
September 3, 2025

Press Release. Comunicado sobre a descontinuação definitiva do produto creme fenergan.

Read more.
Global
2025
August 27, 2025

Press Release. Opella secures non-prescription approval of Cialis in Norway.

Read more.
Brazil
2025
July 30, 2025

Comunicado. Reativação dos medicamentos Mucosolvan Xarope Adulto 6mg/ml (120 ml) e Mucosolvan Xarope Pediátrico 3 mg/ml (120ml).

Read more.
Brazil
2025

Comunicado. Reativação dos medicamentos Bisolvon Xarope Adulto 8mg/5ml (120 ml) e Bisolvon Xarope Infantil 4 mg/5ml (120 ml).

Read more.
Germany
2025
July 8, 2025

Pressemitteilung. Opella ernennt Jennifer Cerny zur Geschäftsführerin von Opella Deutschland.​

Read more.
Global
2025
June 26, 2025

Press Release. Opella achieves global B Corp certification, redefining leadership in self-care.

Read more.
France
2025
June 26, 2025

Communiqué de Presse. Certifiée B Corp, Opella redéfinit le leadership dans la santé du quotidien.

Read more.
Brazil
2025
June 4, 2025

Comunicado. Reativação de fabricação do medicamento Fenergan 25mg 20 comprimidos (cloridrato de prometazina).

Read more.
France
2025
May 6, 2025

Communiqué de Presse. Ségolène de Marsac nommée Présidente-Directrice Générale d’Opella France.

Read more.
Global
2025
April 30, 2025

Press Release. Opella launches as an independent company to redefine the future of self-care.

Read more.
Brazil
2025
April 22, 2025

Comunicado. Reativação de fabricação/importação do medicamento NOVALGINA® supositório 300 mg (dipirona sódica monoidratada).

Read more.
Brazil
2025
April 22, 2025

Comunicado. Reativação de fabricação/importação do medicamento ALLEGRA D® comprimidos (cloridrato de fexofenadina 60 mg + cloridrato de pseudoefedrina 120 mg).

Read more.
Global
2024
October 21, 2024

Press Release. Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare.

Read more.